Page last updated: 2024-11-01

ondansetron and Asthma

ondansetron has been researched along with Asthma in 2 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kiernan, E1
Jones, KL1
Milne, RJ1

Reviews

1 review available for ondansetron and Asthma

ArticleYear
Medications that Cause Fetal Anomalies and Possible Prevention Strategies.
    Clinics in perinatology, 2019, Volume: 46, Issue:2

    Topics: Abnormalities, Drug-Induced; Acetaminophen; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Analg

2019

Other Studies

1 other study available for ondansetron and Asthma

ArticleYear
Evaluation of the pharmacoeconomic literature.
    PharmacoEconomics, 1994, Volume: 6, Issue:4

    Topics: Asthma; Bronchodilator Agents; Child; Cisplatin; Economics, Pharmaceutical; Forecasting; Humans; Ond

1994